39 related articles for article (PubMed ID: 25004829)
21. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.
Rychtarcikova Z; Lettlova S; Tomkova V; Korenkova V; Langerova L; Simonova E; Zjablovskaja P; Alberich-Jorda M; Neuzil J; Truksa J
Oncotarget; 2017 Jan; 8(4):6376-6398. PubMed ID: 28031527
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study.
De Iuliis V; Gelormini R; Flacco M; Moriello G; Caruso M; Barone E; Golato M; Toniato E; Conti P; Martinotti S
Drugs Real World Outcomes; 2016 Mar; 3(1):7-12. PubMed ID: 27747801
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).
Reichl P; Mikulits W
Oncol Rep; 2016 Aug; 36(2):613-25. PubMed ID: 27278244
[TBL] [Abstract][Full Text] [Related]
24. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.
He F; Wei L; Luo W; Liao Z; Li B; Zhou X; Xiao X; You J; Chen Y; Zheng S; Li P; Murata M; Huang G; Zhang Z
Oncotarget; 2016 Jun; 7(24):37000-37012. PubMed ID: 27203742
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer.
Zhang W; Zheng X; Wang X
Am J Cancer Res; 2015; 5(9):2788-98. PubMed ID: 26609484
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma.
Li C; Peng Y; Mao B; Qian K
Oncotarget; 2015 Jul; 6(19):17792-804. PubMed ID: 25970775
[TBL] [Abstract][Full Text] [Related]
27. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
28. A single glutaredoxin or thioredoxin gene is essential for viability in the yeast Saccharomyces cerevisiae.
Draculic T; Dawes IW; Grant CM
Mol Microbiol; 2000 Jun; 36(5):1167-74. PubMed ID: 10844700
[TBL] [Abstract][Full Text] [Related]
29. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
30. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
31. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
32. Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome.
Mollbrink A; Jawad R; Vlamis-Gardikas A; Edenvik P; Isaksson B; Danielsson O; Stål P; Fernandes AP
Int J Immunopathol Pharmacol; 2014; 27(2):169-83. PubMed ID: 25004829
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
